Page last updated: 2024-11-03

pyrimethamine and Hemorrhagic Thrombocythemia

pyrimethamine has been researched along with Hemorrhagic Thrombocythemia in 2 studies

Maloprim: contains above 2 cpds

Research Excerpts

ExcerptRelevanceReference
"Eight patients with myeloproliferative disorders, five with polycythaemia rubra vera (PRV) and three with essential thrombocythaemia (ET), have been treated with the anti-folate drug Pyrimethamine for periods ranging from 1 to 24 years."7.67Pyrimethamine in the myeloproliferative disorders: a forgotten treatment? ( Bowcock, SJ; Linch, DC; Machin, SJ; Stewart, JW, 1987)
"Eight patients with myeloproliferative disorders, five with polycythaemia rubra vera (PRV) and three with essential thrombocythaemia (ET), have been treated with the anti-folate drug Pyrimethamine for periods ranging from 1 to 24 years."3.67Pyrimethamine in the myeloproliferative disorders: a forgotten treatment? ( Bowcock, SJ; Linch, DC; Machin, SJ; Stewart, JW, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Linker, H1
Lindner, HJ1
Reuter, H1
Gross, R1
Bowcock, SJ1
Linch, DC1
Machin, SJ1
Stewart, JW1

Other Studies

2 other studies available for pyrimethamine and Hemorrhagic Thrombocythemia

ArticleYear
[Long-term treatment of thrombocytosis and thrombocythemia].
    Die Medizinische Welt, 1980, Apr-04, Volume: 31, Issue:14

    Topics: Busulfan; Humans; Myeloproliferative Disorders; Pyrimethamine; Thrombocythemia, Essential; Thrombocy

1980
Pyrimethamine in the myeloproliferative disorders: a forgotten treatment?
    Clinical and laboratory haematology, 1987, Volume: 9, Issue:2

    Topics: Adult; Aged; Child; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myeloproliferative Disorde

1987